Unicycive Therapeutics, Inc. Common Stock

UNCYNASDAQ • USD
3.53 USD
↘ 0.04 (1.12%)AT CLOSE (03:59 PM EST)
3.56
↗ 0.03 (0.85%)
POST MARKET (AS OF 07:58 PM EST)
Post Market
AS OF 07:58 PM EST
3.56
↗ 0.03 (0.85%)
🔴Market: CLOSED

UNCY is currently priced at $3.53. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, UNCY appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Nov 19, 2026.

Open?$3.56
High?$3.65
Low?$3.42
Prev. Close?$3.57
Volume?886.1K
Avg. Volume?1.1M
VWAP?$3.51
Rel. Volume?0.82x
Bid / Ask
Bid?$3.53 × 300
Ask?$3.60 × 1.4K
Spread?$0.07
Midpoint?$3.57
Valuation & Ratios
Market Cap?103.0M
Shares Out?27.9M
Float?27.4M
Float %?98.2%
P/E Ratio?N/A
P/B Ratio?1.96
EPS?-$1.24
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.
Employees
22
Market Cap
104.2M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-07-13
Address
1975 W. EL CAMINO REAL, SUITE 204
MOUNTAIN VIEW, CA 94040
Phone: 650-384-0642
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
2
Momentum?
50
Short Sent.?
51
Piotroski F-Score?0/9Weak
Altman Z-Score?-0.16Distress
Confidence?55%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?17.62%High
Short Interest?4.8M
Days to Cover?4.2
Free Float27.4M
Avg Daily Volume1.2M
Settlement Date2026-10-30
Financial Health
Current Ratio?4.00Strong
Quick Ratio?4.00Strong
Cash Ratio?2.42Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
75
1.96CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.8CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-68.8%WEAK▾
ROA?
S&P
3
-51.8%WEAK▾
Cash Flow & Enterprise
FCF?$-29354000
Enterprise Value?$61.1M
Fundamentals ratios updated end of day